Skip to main content
Caplight Logo









AfaSci, Inc.

AfaSci, Inc.

Private
Burlingame, CaliforniaHealthcare & Life Scienceshttps://afasci.com/

Total Funding Raised

$5.2M

Company Overview

AfaSci, Inc. is a biopharmaceutical company that discovers and develops peptide and small molecule therapies for neurological disorders, while also providing contract research services and commercializing rodent behavioral monitoring instruments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

small molecule therapeuticsCNS disordersnon-opioid analgesicspreclinical contract researchrodent behavioral monitoringelectrophysiology servicespharmacokinetic testingPK/PD testingin vivo pharmacologyCROlab automationdrug discovery toolsphenotypic screeningbiotech equipmentpain management research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AfaSci, Inc. Comparables

Compare AfaSci, Inc. with similar companies based on industry and business-model similarity.

AfaSci, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EicOsis Human Health, Inc.
76%
Harvard Bioscience
69%
Clever Sys, Inc.
64%

AfaSci, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Xinmin Simon Xie

President and Chief Executive Officer

Executive Team

Sue Li

CFO

Executive Team

AfaSci, Inc. Investors

Notable investors and investment history

AfaSci, Inc. investors
InvestorRounds
NIH RADxGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 85% MoM.

  • Jan 20, 2026

    Monthly visitors increased 154% MoM.

AfaSci, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AfaSci, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AfaSci, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBurlingame, California
Employee Range16
Year Founded2003
Last Funding

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?